Houston, TX – M D Anderson Clinical Trials

Melanoma Clinical Trials- Recruiting

Phase

   

NCT01010984

LC Bead Embolization Agent With Doxorubicin in the Treatment Liver Metastasis From Melanoma

Phase 1

NCT01546571

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Phase 3

NCT00297895

Multicenter Selective Lymphadenectomy Trial II (MSLT-II)

Phase 3

NCT01127594

Evaluate Safety/Tolerability Intra-Arterial Temozolomide in Patients w/Extremity Melanoma by Isolated Limb Infusion

Phase 1

NCT00507325

Sample Collection From Melanoma Patients

 

NCT00386906

Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma

Phase 1

NCT01092728

Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma

Phase 2

NCT01340729

Open-Label Study of TPI 287 for Patients With Metastatic Melanoma

Phase 1| Phase 2

NCT01409174

IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma

Phase 1| Phase 2

NCT01585194

Ipilimumab for Uveal Melanoma

Phase 1| Phase 2

NCT01590082

Doxycycline, Temozolomide and Ipilimumab in Melanoma

Phase 1| Phase 2

NCT01067066

A Phase I/II Study of TPI 287 – Temozolomide Combination in Melanoma

Phase 1| Phase 2

NCT01644591

Melanoma Gamma Knife

Phase 3

NCT00495950

Prospective Measurement of Post-Treatment Lymphedema

 

NCT01200342

Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma

Phase 2

NCT01295931

Nuclear and Near-Infrared (NIR) Imaging in Melanoma

Phase 1

NCT00116363

Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma

Phase 2

NCT00833807

Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the Liver

Phase 1

NCT01266603

High-dose Interleukin-2 (HDIL-2), Combined With recMAGE-A3 + AS15 ASCI

Phase 2

NCT01039844

Study of Weekly LOC-paclitaxel Injection for Melanoma

Phase 1

NCT01092585

Tesetaxel as Second-line Therapy for Patients With Advanced Melanoma and Normal Serum LDH

Phase 2

NCT00338377

Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization

Phase 2

NCT01433302

Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass

 

NCT00960752

Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist

Phase 2

NCT01665183

Phase 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Argininousccinate Synthetase Deficient Advanced Tumors

Phase 1

NCT01596140

Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer

Phase 1

NCT01337765

Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients

Phase 1

NCT01624220

Spinal Stereotactic Body Radiation Therapy

 

NCT01311843

Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT)

 

NCT01412749

TEST: Registry for Endoscopic Head and Neck Surgery

 

NCT01183663

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Phase 1

NCT00911326

Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma

Phase 3

NCT01327053

A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma

Phase 2

Updated from clinicaltrials.gov on 9/08/2012

 
Advertisements

Leave a comment

Filed under Uncategorized

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s